ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 020

Building Consensus on Key Research Domains and Research Topics in Childhood-onset Neuropsychiatric Lupus: An International Prioritization Initiative

Ekemini Ogbu1, Martha Rodriguez2, Alexandra Theisen3, Simone Appenzeller4, Emily Beil5, Onengiya Harry6, Ryan Kammeyer7, Natoshia Cunningham8, Kristen Fisher9, Marisa Klein-Gitelman10, Monica Banks11, Eyal Muscal12, Sefi Kronenberg13, Paige Seegan14, Lawrence Ng15, Marietta DeGuzman12, Mckenna Bowes16, Kiana Johnson17, Y. Ingrid Goh18, Eve Smith19, Katerina Bouchalova20, Lea Höfel21, Jainish Patel1, Mekibib Altaye22, Rashmi Sahay23, Susanne Benseler24, Hermine Brunner1 and Andrea Knight25, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Riley Hospital For Children At Indiana University, Carmel, IN, 3Riley Hospital for Children at Indiana University, 4Universidade Estadual de Campinas, Brazil, 5Atrium Health, Levine Children's Hospital, 6Atrium Health Wake Forest School of Medicine, 7Departments of Pediatrics and Neurology, University of Colorado School of Medicine, Aurora, CO, 8Michigan State University, Grand Rapids, 9Baylor College of Medicine, 10Ann & Robert H. Lurie Children's Hospital Chicago, Chicago, IL, 11Family Advisory Council, Neuropsychiatric Workgroup, Childhood Arthritis and Rheumatology Research Alliance, 12Baylor College of Medicine, houston, TX, 13The Hospital for Sick Children and University of Toronto, 14Johns Hopkins School of Medicine, Baltimore, MD, 15The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 16West Virginia University School of Medicine, Morgantown, WV, 17East Tennessee State Universityy, TN, 18The Hospital for Sick Children, 19University of Glasgow, Glasgow, Scotland, United Kingdom, 20Palacky University Olomouc, Olomouc, Czech Republic, 21Pediatric clinic Garmisch-Partenkirchen / Germany, Garmisch-Partenkirchen, Bayern, Germany, 22Cincinnati Children's Hospital, Cincinnati, 23Cincinnati Children's Hospital Medical Center, OH, 24Children’s health Ireland, Dublin, Dublin, Ireland, 25Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a major end-organ manifestation of childhood-onset systemic lupus erythematosus (cSLE) and is poorly understood. High-quality, collaborative and patient-centered studies are critically needed to address important gaps in scientific understanding knowledge and evidence-based care of NPSLE. Thus, our objective was to build consensus on key research domains and topics for NPSLE using a modified Delphi-based process integrating clinician, researcher, and family perspectives.

Methods: A multidisciplinary, international NPSLE taskforce comprised of pediatric rheumatologists, pediatric neuroimmunologist, psychiatrists, psychologists, research coordinators, and a family advisory council (FAC) of patients and caregivers was reconvened in August 2025. The group met via zoom, with all sessions recorded, to review prior work that identified 12 research domains (each with 4 -13 research topics) and 9 statements on perceived facilitators of NPSLE research. A preliminary Delphi survey was administered to the taskforce via REDCap with a 3-week response period. Each research topic was evaluated on a 5-point Likert scale ranging from Strongly Disagree to Strongly Agree. Members provided explanations for Agree, Disagree, Neutral or Strongly Disagree responses. A consensus threshold of  ≥70% agreement was decided apriori. Between September and October 2025 two meetings were held to review the survey results. Topics and statements meeting agreement threshold were finalized, while those requiring clarification were revised and moved to the Welphi® platform – an online Delphi tool supporting live and asynchronous voting across multiple rounds.

Results:  Of 29 taskforce members invited, 25 agreed to participate in the initial online survey, and 20 completed it (80% response rate; one incomplete). Taskforce demographics are shown in Table 1. Across all research domains, 34 research topics and 7 facilitator statements met the ≥70% agreement threshold and were accepted into the final survey. Nine topics met the overall threshold but lacked strong agreement; however, they remained unedited and were included in the final survey. Twenty-six research topics and 2 facilitator statements required minor edits and were advanced to the Welphi platform for additional voting, while 1 topic that did not meet the threshold was carried forward to Welphi for re-evaluation. Fourteen members participated in the Welphi voting (7 during the live session and 7 asynchronously). In Round 1, all research topics reached consensus, while one overlapping topic (Domain 4, Topic 2) was dropped. Table 2 summarizes change in agreement between the initial and Welphi surveys.

Conclusion: Through a structured modified Delphi process combining initial online survey and Welphi rounds, the Taskforce achieved consensus on key pediatric NPSLE research priorities, laying a foundation for further patient-centered studies aimed at improving care and outcomes for childhood-onset NPSLE.

Table 1Supporting image 1

Table 2Supporting image 2


Disclosures: E. Ogbu: None; M. Rodriguez: None; A. Theisen: None; S. Appenzeller: None; E. Beil: None; O. Harry: None; R. Kammeyer: Amgen, 6, Novartis, 6; N. Cunningham: None; K. Fisher: None; M. Klein-Gitelman: AstraZeneca, 2; M. Banks: None; E. Muscal: Sobi, 1; S. Kronenberg: None; P. Seegan: None; L. Ng: None; M. DeGuzman: None; M. Bowes: None; K. Johnson: None; Y. Goh: None; E. Smith: None; K. Bouchalova: None; L. Höfel: TEVA, 1; J. Patel: None; M. Altaye: None; R. Sahay: None; S. Benseler: None; H. Brunner: None; A. Knight: None.

To cite this abstract in AMA style:

Ogbu E, Rodriguez M, Theisen A, Appenzeller S, Beil E, Harry O, Kammeyer R, Cunningham N, Fisher K, Klein-Gitelman M, Banks M, Muscal E, Kronenberg S, Seegan P, Ng L, DeGuzman M, Bowes M, Johnson K, Goh Y, Smith E, Bouchalova K, Höfel L, Patel J, Altaye M, Sahay R, Benseler S, Brunner H, Knight A. Building Consensus on Key Research Domains and Research Topics in Childhood-onset Neuropsychiatric Lupus: An International Prioritization Initiative [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/building-consensus-on-key-research-domains-and-research-topics-in-childhood-onset-neuropsychiatric-lupus-an-international-prioritization-initiative/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/building-consensus-on-key-research-domains-and-research-topics-in-childhood-onset-neuropsychiatric-lupus-an-international-prioritization-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology